GLPBio

Apoptosis

Read More about this category

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

 

References:

1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.

2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.

3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.

4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.

5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Research Areas

Products Related to Apoptosis(3030)

  • GN10045 structure
    GN10045Angelicin
    CAS: 523-50-2
    Purity: >99.50%
  • GN10055 structure
    GN10055Mulberroside A
    CAS: 102841-42-9
    Purity: >98.00%
  • GN10056 structure
    GN10056Dihydroartemisinin
    CAS: 71939-50-9
    Purity: >98.00%

    Dihydroartemisinin (DHA)은 아르테미시닌과 그 유래물 (ARTs)의 활성 메타볼라이트이고 말라리아를 치료하기 위해 임상에서 널리 사용되는 효과적인 약물이다.

  • GN10065 structure
    GN100652-Atractylenolide
    CAS: 73069-14-4
    Purity: >98.00%
  • GN10076 structure
    GN10076Geniposidic acid
    CAS: 27741-01-1
    Purity: >98.00%
  • GN10082 structure
    GN10082Gossypol
    CAS: 303-45-7
    Purity: >99.50%

    Gossypol is a lipid-soluble polyphenolic compound extracted from the cotton plant with antifertility, antioxidant, and anticancer properties.

  • GN10088 structure
    GN10088Isoliquiritigenin
    CAS: 961-29-5
    Purity: >98.00%

    Isoliquiritigenin은 감초에서 추출한 플라보노이드 화합물이다. Isoliquiritigenin은 Nrf2 경로를 활성화해서 산화적 스트레스와 염증을 감소시키고 세포 사멸을 유도해서 암 진행을 억제할 수 있다.

  • GN10093 structure
    GN100936-gingerol
    CAS: 23513-14-6
    Purity: >98.00%

    6-gingerol is an active compound isolated from Ginger with anticancer, anti-inflammation, and anti-oxidation activities.

  • GN10103 structure
    GN10103Neferine
    CAS: 2292-16-2
    Purity: >99.50%

    Neferine (NEF)은 전통 한약 Nelumbinis plumula에서 분리된 천연 이중 벤질 이소퀴놀린 알칼로이드이다. Neferine은 다양한 약리학적 특성을 가지고 있다.

  • GN10107 structure
    GN10107Tubeimoside I
    CAS: 102040-03-9
    Purity: >98.00%
  • GN10109 structure
    GN10109Ganoderic Acid A
    CAS: 81907-62-2
    Purity: >98.00%

    Ganoderic Acid A는 Ganoderma lucidum에서 유래한 트리터페노이드 화합물로 다양한 생물학적 활성을 가진다.

  • GN10113 structure
    GN10113Cepharanthine
    CAS: 481-49-2
    Purity: >98.00%

    Cepharanthine은 SARS-CoV-2와 HIV-1에 대해 EC50 값이 각각 0.15μM과 0.026μM인 강력한 항바이러스 활성을 가진 디벤질이소팜린 베르베린이다.

  • GN10122 structure
    GN10122Linalool
    CAS: 78-70-6
    Purity: >98.00%
  • GN10123 structure
    GN10123Columbianadin
    CAS: 5058-13-9
    Purity: >98.00%
  • GN10127 structure
    GN10127Salidroside
    CAS: 10338-51-9
    Purity: >98.50%

    Salidroside는 주로 례디오라 종의 뿌리에서 발견되는 틸로졸 글루코사이드로, 항암, 항산화, 항노화, 항당뇨, 항고혈압, 항염증 및 면역조절 효과를 포함한 다양한 생물학적 및 약리학적 특성을 가지고 있다.

  • GN10129 structure
    GN10129Polyphyllin VII
    CAS: 76296-75-8
    Purity: >98%
  • GN10142 structure
    GN10142Lupeol
    CAS: 545-47-1
    Purity: >98.00%
  • GN10144 structure
    GN10144Oleandrin
    CAS: 465-16-7
    Purity: >99.00%
  • GN10148 structure
    GN10148Ginsenoside F2
    CAS: 62025-49-4
    Purity: >98.00%
  • GN10151 structure
    GN10151Geraniin
    CAS: 60976-49-0
    Purity: >98.00%

    Geraniin은 IC50 값이 43μM인 TNF-α 방출 억제제로 항암, 항염증 및 항고혈당 활성을 포함한 다양한 활성을 나타낸다.

  • GN10173 structure
    GN10173Madecassoside
    CAS: 34540-22-2
    Purity: >99.50%
  • GN10189 structure
    GN10189Cinobufagin
    CAS: 470-37-1
    Purity: >98.00%
  • GN10203 structure
    GN10203Ziyuglycoside I
    CAS: 35286-58-9
    Purity: >99.00%
  • GN10213 structure
    GN10213Sinomenine Hydrochloride
    CAS: 6080-33-7
    Purity: >99.50%

    Sinomenine Hydrochloride은 NF-κB 활성을 억제하는 억제제이다.